Comparison of Hospital Readmission and Mortality between COVID-19 and Pneumonia Patients

1Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Coronavirus disease 2019 (COVID-19) survivors can have lasting signs and symptoms, including various organ damage, indicating that COVID-19 can be a chronic illness. The current study aims to compare the 30-day hospital readmission and death rate of patients admitted to the hospital with COVID-19 and pneumonia due to other causes. A retrospective cohort study was conducted using data from the Saudi National Guard Health Affairs (NGHA). Records of patients admitted with COVID-19 between 1 March 202 and 31 December 2020 (n = 3597) and pneumonia during 2017 and 2019 (n = 6324) were retrieved and analyzed. We compared the likelihood of 30-day hospital readmission, intensive care unit (ICU) admission, and death between the two groups. Compared with the control group, COVID-19 patients had higher odds of 30-day readmission (odds ratio 1.90, 95% confidence interval 1.61–2.24), higher risk of ICU transfer (hazard ratio 1.85, 95% confidence interval 1.65–2.07), more extended hospital stay (7 vs. 4 days), but less risk of death (hazard ratio 0.18, 95% confidence interval 0.14–0.24). The findings that hospital readmission was higher in COVID-19 recovered patients than in other pneumonia patients inform the current discussion about readmission and death in COVID-19 patients.

Cite

CITATION STYLE

APA

Alyabsi, M., Aldibasi, O., Bosaeed, M., Alanazi, M., Alqarni, A., Albdah, B., … Alghnam, S. (2022). Comparison of Hospital Readmission and Mortality between COVID-19 and Pneumonia Patients. Journal of Clinical Medicine, 11(14). https://doi.org/10.3390/jcm11144199

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free